Correction to NPS Hormone Drug Article on Friday
24 Janvier 2015 - 11:40PM
Dow Jones News
NPS announced in December that the European Medicines Agency
validated its marketing authorization application and started its
review of the drug. "NPS Hormone Drug Gets FDA Approval," at 7:54
p.m. EST on Friday, misstated the drug got EMA approval in the
ninth paragraph.
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Nps (NASDAQ:NPSP)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Nps (NASDAQ:NPSP)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about (MM) (NASDAQ): 0 recent articles
Plus d'articles sur NPS Pharmaceuticals Inc.